AR076338A1 - Disoluciones pediatricas para beta-bloqueantes - Google Patents
Disoluciones pediatricas para beta-bloqueantesInfo
- Publication number
- AR076338A1 AR076338A1 ARP100101299A ARP100101299A AR076338A1 AR 076338 A1 AR076338 A1 AR 076338A1 AR P100101299 A ARP100101299 A AR P100101299A AR P100101299 A ARP100101299 A AR P100101299A AR 076338 A1 AR076338 A1 AR 076338A1
- Authority
- AR
- Argentina
- Prior art keywords
- beta
- propanolol
- solution according
- solutions
- preservative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente se refiere a disoluciones acuosas no alcoholicas que comprenden un beta-bloqueante, un edulcorante tipo no azucarado y básicamente sin un agente conservante aromático. Las disoluciones de la presente solicitud están especialmente adaptadas para uso pediátrico Reivindicacion 2: La disolucion acuosa segun una cualquiera de las reivindicaciones 1, en la que al menos un beta-bloqueante se selecciona de beta-bloqueantes no selectivos, por ejemplo, de alprenolol, bucindolol, carteolol, carvedilol, labetalol, levobunolol, medroxalol, mepindolol, metipranolol, nadolol, oxprenolol, penbutolol, pindolol, propafenona, propanolol, sotalol, timolol, sales farmacéuticamente aceptables de los mismos y, por ejemplo, propanolol o una sal farmacéuticamente aceptable del mismo, y está presente en una cantidad del 0,01 al 5% p/v. Reivindicacion 3: La disolucion acuosa segun una cualquiera de las reivindicaciones 1 o 2, que comprende además al menos un agente aromatizante y/o al menos un agente de aumento de la viscosidad. Reivindicacion 16: La disolucion segun una cualquiera de las reivindicaciones 1 a 15, para uso como un medicamento en el tratamiento de hemangiomas, por ejemplo, hemangiomas capilares y, por ejemplo, hemangiomas capilares infantiles. Reivindicacion 20: El uso de propanolol como un agente conservante. Reivindicacion 21: El uso de propanolol y aromatizante de vainilla como un agente conservante.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09290298A EP2246044A1 (en) | 2009-04-21 | 2009-04-21 | Paediatric solutions comprising a beta-blocker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR076338A1 true AR076338A1 (es) | 2011-06-01 |
Family
ID=40940328
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100101299A AR076338A1 (es) | 2009-04-21 | 2010-04-20 | Disoluciones pediatricas para beta-bloqueantes |
| ARP190102095A AR117621A2 (es) | 2009-04-21 | 2019-07-25 | UNA SOLUCIÓN ACUOSA SIN ALCOHOL ETÍLICO QUE COMPRENDE UN b-BLOQUEANTE Y DISPOSITIVO |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190102095A AR117621A2 (es) | 2009-04-21 | 2019-07-25 | UNA SOLUCIÓN ACUOSA SIN ALCOHOL ETÍLICO QUE COMPRENDE UN b-BLOQUEANTE Y DISPOSITIVO |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US20120035270A1 (es) |
| EP (4) | EP2246044A1 (es) |
| JP (1) | JP5695029B2 (es) |
| KR (1) | KR101713866B1 (es) |
| CN (1) | CN102405041A (es) |
| AR (2) | AR076338A1 (es) |
| AU (1) | AU2010240551B2 (es) |
| BR (1) | BRPI1015447B1 (es) |
| CA (1) | CA2755175C (es) |
| CL (1) | CL2011002634A1 (es) |
| CO (1) | CO6410278A2 (es) |
| CY (2) | CY1119390T1 (es) |
| DK (2) | DK2421504T4 (es) |
| ES (2) | ES2623936T5 (es) |
| GE (1) | GEP20146087B (es) |
| HR (2) | HRP20170610T4 (es) |
| HU (2) | HUE039937T2 (es) |
| IL (1) | IL214674A (es) |
| LT (2) | LT2497461T (es) |
| MA (1) | MA33003B1 (es) |
| MX (1) | MX337463B (es) |
| NZ (1) | NZ594592A (es) |
| PL (2) | PL2421504T5 (es) |
| PT (2) | PT2421504T (es) |
| RS (2) | RS55862B2 (es) |
| RU (1) | RU2011139233A (es) |
| SG (1) | SG172960A1 (es) |
| SI (2) | SI2497461T2 (es) |
| TN (1) | TN2011000350A1 (es) |
| TW (1) | TWI429459B (es) |
| UA (1) | UA107570C2 (es) |
| WO (1) | WO2010122442A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2246044A1 (en) | 2009-04-21 | 2010-11-03 | Pierre Fabre Dermo-Cosmétique | Paediatric solutions comprising a beta-blocker |
| JP2019142972A (ja) * | 2011-03-04 | 2019-08-29 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | タペンタドールの非経口的投与 |
| DK2680833T3 (en) * | 2011-03-04 | 2016-05-23 | Gruenenthal Gmbh | PARENTERAL SUBMISSION OF TAPENTADOL |
| SI2680832T1 (sl) | 2011-03-04 | 2019-11-29 | Gruenenthal Gmbh | Vodna farmacevtska formulacija tapentadola za peroralno dovajanje |
| US9724297B2 (en) | 2014-04-01 | 2017-08-08 | Arbor Pharmaceuticals, Inc. | Sotalol compositions and uses of the same |
| CN107847471A (zh) | 2015-03-27 | 2018-03-27 | 格吕伦塔尔有限公司 | 他喷他多肠胃外给药的稳定制剂 |
| EP3515412A1 (en) | 2016-09-23 | 2019-07-31 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
| CN108261411B (zh) * | 2016-12-30 | 2021-04-30 | 武汉科福新药有限责任公司 | 用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法 |
| CN107320467A (zh) * | 2017-07-21 | 2017-11-07 | 江苏云阳集团药业有限公司 | 一种盐酸普萘洛尔药用组合物及其制备方法 |
| CN108299279B (zh) * | 2018-02-09 | 2021-03-23 | 北京梅尔森医药技术开发有限公司 | 取代芳基胺醇化合物及其制备方法和用途 |
| US11547123B2 (en) * | 2019-08-16 | 2023-01-10 | The Folger Coffee Company | Methods for reducing negative flavor attributes in coffee and compositions therefrom |
| US20230364242A1 (en) | 2020-09-30 | 2023-11-16 | Nissan Chemical Corporation | Water-soluble complex containing beta blocker and lecithin |
| GB2628566A (en) | 2023-03-29 | 2024-10-02 | Novumgen Ltd | An orally rapidly disintegrating tablet of propranolol and its process of preparation |
| CN118021718B (zh) * | 2024-04-12 | 2024-07-02 | 成都瑞尔医药科技有限公司 | 一种盐酸普罗帕酮注射液及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4600708A (en) | 1985-07-19 | 1986-07-15 | American Home Products Corporation | Propranolol hydrochloride liquid formulations |
| HU209251B (en) | 1992-03-13 | 1994-04-28 | Synepos Ag | Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons |
| DE69613164T2 (de) | 1995-03-15 | 2001-09-27 | Kao Corp | Verwendung eines Zusatzstoffes zur Verminderung von Bittergeschmack |
| JPH1025253A (ja) * | 1996-07-12 | 1998-01-27 | Kao Corp | 苦味低減化剤及び苦味低減化法 |
| JPH11349492A (ja) * | 1998-06-03 | 1999-12-21 | Yamanouchi Pharmaceut Co Ltd | 苦味を低減した経口用医薬組成物および苦味低減化方法 |
| JP2001342151A (ja) * | 2000-03-31 | 2001-12-11 | Eisai Co Ltd | 甘味を有する薬剤組成物 |
| SK286227B6 (sk) * | 2001-05-25 | 2008-05-06 | Warner-Lambert Company Llc | Kvapalná farmaceutická kompozícia obsahujúca analóg GABA a spôsob jej prípravy a použitie |
| EP1543831A1 (en) * | 2003-12-18 | 2005-06-22 | Pfizer GmbH Arzneimittelwerk Gödecke | Pregabalin composition |
| AU2005328349A1 (en) * | 2005-02-25 | 2006-09-08 | Biomarin Pharmaceutical Inc. | Room temperature stable aqueous liquid pharmaceutical composition |
| CN101257889A (zh) * | 2005-05-25 | 2008-09-03 | 詹森药业有限公司 | 托吡酯的儿科制剂 |
| DE102006020604A1 (de) * | 2006-05-02 | 2007-11-08 | Bayer Healthcare Ag | Flüssige Arzneimittelformulierung |
| EP2050441A1 (en) | 2007-10-19 | 2009-04-22 | Université Victor Segalen Bordeaux 2 | Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| UA102254C2 (ru) * | 2008-04-25 | 2013-06-25 | Апотекс Технолоджис Инк. | Жидкий состав для деферипрона с приятным вкусом |
| EP2246044A1 (en) | 2009-04-21 | 2010-11-03 | Pierre Fabre Dermo-Cosmétique | Paediatric solutions comprising a beta-blocker |
-
2009
- 2009-04-21 EP EP09290298A patent/EP2246044A1/en not_active Withdrawn
-
2010
- 2010-04-12 RU RU2011139233/15A patent/RU2011139233A/ru unknown
- 2010-04-12 PT PT107172637T patent/PT2421504T/pt unknown
- 2010-04-12 BR BRPI1015447A patent/BRPI1015447B1/pt active IP Right Grant
- 2010-04-12 ES ES10717263T patent/ES2623936T5/es active Active
- 2010-04-12 EP EP12155472.9A patent/EP2497461B2/en active Active
- 2010-04-12 SI SI201031741T patent/SI2497461T2/sl unknown
- 2010-04-12 RS RS20170358A patent/RS55862B2/sr unknown
- 2010-04-12 GE GEAP201012468A patent/GEP20146087B/en unknown
- 2010-04-12 HU HUE12155472A patent/HUE039937T2/hu unknown
- 2010-04-12 MX MX2011010766A patent/MX337463B/es active IP Right Grant
- 2010-04-12 JP JP2012506607A patent/JP5695029B2/ja active Active
- 2010-04-12 HU HUE10717263A patent/HUE034581T2/en unknown
- 2010-04-12 PT PT12155472T patent/PT2497461T/pt unknown
- 2010-04-12 CN CN2010800174060A patent/CN102405041A/zh active Pending
- 2010-04-12 PL PL10717263.7T patent/PL2421504T5/pl unknown
- 2010-04-12 SG SG2011050663A patent/SG172960A1/en unknown
- 2010-04-12 LT LTEP12155472.9T patent/LT2497461T/lt unknown
- 2010-04-12 EP EP10717263.7A patent/EP2421504B2/en active Active
- 2010-04-12 EP EP18174428.5A patent/EP3384899A1/en active Pending
- 2010-04-12 KR KR1020117024721A patent/KR101713866B1/ko active IP Right Grant
- 2010-04-12 HR HRP20170610TT patent/HRP20170610T4/hr unknown
- 2010-04-12 RS RS20181036A patent/RS57668B2/sr unknown
- 2010-04-12 PL PL12155472T patent/PL2497461T5/pl unknown
- 2010-04-12 AU AU2010240551A patent/AU2010240551B2/en active Active
- 2010-04-12 US US13/265,739 patent/US20120035270A1/en not_active Abandoned
- 2010-04-12 NZ NZ594592A patent/NZ594592A/xx unknown
- 2010-04-12 DK DK10717263.7T patent/DK2421504T4/da active
- 2010-04-12 DK DK12155472.9T patent/DK2497461T4/da active
- 2010-04-12 WO PCT/IB2010/051573 patent/WO2010122442A1/en active Application Filing
- 2010-04-12 SI SI201031439A patent/SI2421504T1/sl unknown
- 2010-04-12 MA MA34064A patent/MA33003B1/fr unknown
- 2010-04-12 LT LTEP10717263.7T patent/LT2421504T/lt unknown
- 2010-04-12 ES ES12155472T patent/ES2685178T5/es active Active
- 2010-04-12 CA CA2755175A patent/CA2755175C/en active Active
- 2010-04-20 TW TW099112270A patent/TWI429459B/zh active
- 2010-04-20 AR ARP100101299A patent/AR076338A1/es not_active Application Discontinuation
- 2010-12-04 UA UAA201112317A patent/UA107570C2/ru unknown
-
2011
- 2011-07-15 TN TN2011000350A patent/TN2011000350A1/fr unknown
- 2011-07-28 CO CO11095137A patent/CO6410278A2/es not_active Application Discontinuation
- 2011-08-15 IL IL214674A patent/IL214674A/en active IP Right Grant
- 2011-10-21 CL CL2011002634A patent/CL2011002634A1/es unknown
-
2014
- 2014-12-01 US US14/556,861 patent/US20150087719A1/en not_active Abandoned
-
2017
- 2017-05-31 CY CY20171100562T patent/CY1119390T1/el unknown
-
2018
- 2018-09-03 HR HRP20181408TT patent/HRP20181408T4/hr unknown
- 2018-09-07 CY CY181100939T patent/CY1120667T1/el unknown
-
2019
- 2019-07-25 AR ARP190102095A patent/AR117621A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR076338A1 (es) | Disoluciones pediatricas para beta-bloqueantes | |
| CO6270209A2 (es) | Un beta bloqueante para el tratamiento de los hemangiomas | |
| GT200800143A (es) | Derivados de pirimidina utilizados como inhibidores de cinasa pi-3 | |
| ES2557303T3 (es) | Agente terapéutico para la estenosis del canal espinal | |
| PA8637201A1 (es) | Difenilimidazopirimidina e-imidazol aminas como inhibidores de la b-secretasa | |
| AR060836A1 (es) | Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido | |
| ES2537539T3 (es) | Composición oftálmica | |
| AR054249A1 (es) | Tratamiento de enfermedades del tejido conectivo de la piel | |
| TW200744678A (en) | Transdermal drug delivery devices containing O-desmethyl venlafaxing (ODV) or its salts | |
| UY30056A1 (es) | Administracion transdermica de meptazinol | |
| ECSP099556A (es) | Nuevos métodos | |
| BR112012010786A2 (pt) | udo de derivados de benzo-heterociclo para medir e tratar câncer ou para inibir metástase de câncer | |
| AR078224A1 (es) | Composicon para el tratamiento del cancer de prostata | |
| CO6251249A2 (es) | Un medicamento que comprende un derivado un derivado de carbostirilo y donepezilo para tratar enfermedad de alzheimer | |
| AR043670A1 (es) | Composicion farmaceutica que contiene lactato y usos de la misma | |
| AR074841A1 (es) | Composicion que comprende aceite de canamo para tratar enfermedades topicas, especialmente el sindrome mano-pie | |
| CR20140005A (es) | Una nueva composición terapéutica que contiene apomorfina como principio activo | |
| AR077125A1 (es) | Combinaciones farmaceuticas utiles para tratar el vhc | |
| BR112012022074A2 (pt) | composição compreendendo como ingredientes ativos l-carnitina em combinação com hidroxiquinurenina-o-beta-dl-glicosídeo, para a prevenção e/ou tratamento de patologias dos olhos devido à radiação ultravioleta | |
| Sánchez-Carpena et al. | Comparison of intravenous dexketoprofen and dipyrone in acute renal colic | |
| BRPI0414343A (pt) | combinações que compreendem ligantes de alfa-2-delta e inibidores da reabsorção de serotonina/noradrenalina | |
| CN101636391B (zh) | 神经病理性疼痛的预防剂和/或治疗剂 | |
| AR025521A1 (es) | UN SISTEMA TERAPÉUTICO PERCUTÁNEO CONSTITUIDO POR UNA CAPA POSTERIOR, POR LO MENOS UNA CAPA MATRIZ QUE CONTIENE PRINCIPIO ACTIVO, QUE PUEDE TENER TAMBIÉN PROPIEDADES AUTOADHESIVAS, ASí COMO CAPA DE PROTECCIoN SEPARABLE | |
| NO20005621L (no) | Nye medikamentkombinasjoner | |
| ES2507517T3 (es) | Agente profiláctico o terapéutico para trastorno de déficit de atención con hiperactividad |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |